GTR Home > Tests > Auricularcondylar Syndrome 1 - GNAI3 Sequencing

Performance Characteristics



  • Entire test performed in-house

Analytical Validity


Mutation analysis as performed her is greater than 99% sensitive.


  • Ellard et al. Practice Guidelines for Sanger Sequencing Analysis and Interpretation. Clinical Molecular Society 2009|Zoccoli et al. Nucleic Acid Sequencing Methods in Diagnostic Laboratory Medicine: an Approved Guideline.

Proficiency Testing (PT)

Is proficiency testing performed for this test? Help

FDA Regulatory Clearances of the Test

FDA Category Designation
FDA exercises enforcement discretion

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.